Foresite Capital Management V
Latest statistics and disclosures from Foresite Capital Management V's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CGEM, Quantum Si, ACRS, KNTE, GMTX, and represent 61.87% of Foresite Capital Management V's stock portfolio.
- Added to shares of these 2 stocks: Quantum Si (+$29M), 23andme Holding (+$8.2M).
- Started 2 new stock positions in Quantum Si, 23andme Holding.
- Reduced shares in these 7 stocks: OLK (-$7.2M), PHVS (-$5.6M), ALXO, LSAQ, Therapeutics Acquisition Cor, Consonance-HFW Acquisition Corp., IMVT.
- Sold out of its positions in Consonance-HFW Acquisition Corp., IMVT, LSAQ, OLK, Therapeutics Acquisition Cor.
- Foresite Capital Management V was a net buyer of stock by $9.7M.
- Foresite Capital Management V has $254M in assets under management (AUM), dropping by -25.28%.
- Central Index Key (CIK): 0001792206
Tip: Access up to 7 years of quarterly data
Positions held by Foresite Capital Management V consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Foresite Capital Management V
Companies in the Foresite Capital Management V portfolio as of the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Cullinan Oncology (CGEM) | 27.7 | $70M | 2.7M | 25.75 | ||
| Quantum-Si Incorporated Com Cl A | 11.3 | $29M | NEW | 2.3M | 12.26 | |
| Aclaris Therapeutics (ACRS) | 8.7 | $22M | 1.3M | 17.56 | ||
| Kinnate Biopharma (KNTE) | 8.0 | $20M | 875k | 23.28 | ||
| Gemini Therapeutics (GMTX) | 6.2 | $16M | 2.4M | 6.47 | ||
| Relay Therapeutics (RLAY) | 5.8 | $15M | 400k | 36.59 | ||
| Alx Oncology Hldgs (ALXO) | 5.0 | $13M | -27% | 231k | 54.68 | |
| Nurix Therapeutics (NRIX) | 4.7 | $12M | 452k | 26.53 | ||
| Hims & Hers Health Com Cl A (HIMS) | 4.5 | $12M | 1.1M | 10.89 | ||
| Population Health Investment Unit (PHICU) | 3.8 | $9.7M | 960k | 10.15 | ||
| 23andMe Holding Com Cl A | 3.2 | $8.2M | NEW | 700k | 11.69 | |
| Pharvaris N V (PHVS) | 2.7 | $6.8M | -45% | 364k | 18.63 | |
| FS Development Corp. II Com Cl A (FSII) | 2.4 | $6.0M | 603k | 9.98 | ||
| Research Alliance Corp. II Com Cl A (RACB) | 2.0 | $5.1M | 500k | 10.14 | ||
Setup an alertForesite Capital Management V will file the next quarterly 13-HR in about 2 months. Would you like to be notified? |
||||||
| Bctg Acquisition Corp (BCTG) | 1.8 | $4.6M | 400k | 11.38 | ||
| Lucira Health (LHDX) | 1.3 | $3.2M | 485k | 6.64 | ||
| Helix Acquisition Corp. Com Cl A (HLXA) | 1.0 | $2.6M | 250k | 10.35 | ||
Past Filings by Foresite Capital Management V
SEC 13F filings are viewable for Foresite Capital Management V going back to 2020
- Foresite Capital Management V 2021 Q2 filed Aug. 16, 2021
- Foresite Capital Management V 2021 Q1 filed May 17, 2021
- Foresite Capital Management V 2020 Q4 filed Feb. 16, 2021